Home' Australian Pharmacist : Australian Pharmacist January 2017 Contents Australian Pharmacist January 2017 I ©Pharmaceutical Society of Australia Ltd.
Firstly, Dr Emerson can you summarise 2016
for PSA in a few sentences?
The past year has been a busy and
successful time for PSA, especially after
we were recognised by the Federal
Government as the peak organisation for
all registered pharmacists in Australia,
no matter their area of practice, which is
something we are very proud of.
PSA’s peak national body funding enables
us to continue to strongly advocate for
pharmacists practising to their full scope,
create new roles and opportunities, and help
our members achieve their career goals.
PSA’s work with Government has
increased dramatically and we are actively
participating in more government
committees and advisory groups than ever,
continuing to provide the evidence-based
policy advice our peak status recognises.
I understand PSA has also been advocating
for new and improved pharmacist
That’s correct. We’re acutely aware
that pharmacist wages, particularly in
community pharmacy, are stagnant and
even declining in real terms in some areas.
The latest statistics show gross profits per
script peaked a few years ago – and we
know that historically, as profits decrease,
wages also fall.
The single funder PBS model in community
pharmacy needs to be augmented through
additional funding sources.
We are actively progressing new funding
sources from the government, health
insurers and consumers, as well as helping
pharmacies embrace a more value-driven,
Another highlight was PSA’s national
roadshow – how did it help members?
Our first nationwide roadshow was a
success, allowing us to engage with PSA
members, non-members and healthcare
leaders, especially in regional locations.
Overall, we reached more than 1,000
pharmacists across the country, starting
in Brisbane in February and finishing in
Canberra a month later.
The roadshow also provided an ideal
opportunity to update pharmacists on
PSA’s policy and advocacy agenda and
initiatives. We covered 15,000 kilometres
and attracted many new members.
Part of the roadshow was launching Health
Destination Pharmacy. How is this evidence-
based program progressing?
Following extensive research and testing,
the launch of the Health Destination
program was an exciting event for PSA
and our industry partners who backed
the program and formed its advisory
group. The whole-of-business change
program provides everything a pharmacy
needs to transform into a health
destination and increase engagement
with the local community. We want to
raise consumer awareness of the value
that community pharmacies can deliver
through professional services and tailored
As the peak national body for pharmacists, PSA has achieved outstanding
success and wins for pharmacists over the past 12 months.
To reflect on these pioneering achievements and preview the exciting year ahead,
PSA’s Communications Officer Jarryd Luke enjoyed a one-on-one chat with PSA CEO
Dr Lance Emerson.
& exciting times ahead
So far, around 30 pharmacies have signed
up to the program and are performing
more than three times better on key metrics
than non-Health Destination pharmacies,
according to independent research.
This is very encouraging because it shows
that consumers value a healthcare model in
pharmacies, and are willing to pay for this
As the Health Destination model is
underpinned by a minor ailments service
protocol, I believe that ultimately Health
Destination will reduce hospitalisations and
unnecessary emergency room and GP visits,
which in turn will benefit Australia’s health
It must have been great to see the Health
Destination program receiving a major
international Award? How does it feel to
be recognised by the leading international
pharmacy organisation, FIP?
This Award was a testament to all the hard
work that has gone into Health Destination –
the research, piloting and industry support, it’s
all been many, many years in the making.
We were delighted when the program
won the International Pharmaceutical
Federation’s (FIP) inaugural Pharmacy
Practice Improvement Programme Award.
Health Destination’s international success
clearly shows that Australian pharmacies
have backed the right program for a viable
community pharmacy sector. Community
pharmacy owners now have an informed
choice when seeking assistance to help
improve their businesses.
It was also rewarding to see PSA’s Executive
Director of Policy, Advocacy and Innovation,
Dr Alison Roberts receive the UTS / Astra
Links Archive Australian Pharmacist December2016 Navigation Previous Page Next Page